Compare · FMS vs NUWE

FMS vs NUWE

Side-by-side comparison of Fresenius Medical Care AG (FMS) and Nuwellis Inc. (NUWE): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both companies sit in the Health Care sector. FMS focuses on Misc Health and Biotechnology Services, while NUWE focuses on Biotechnology: Electromedical & Electrotherapeutic Apparatus.
  • FMS is the larger of the two at $11.41B, about 6188.4x NUWE ($1.8M).
  • NUWE has been more active in the news (9 items in the past 4 weeks vs 6 for FMS).
  • FMS has more recent analyst coverage (25 ratings vs 1 for NUWE).
MetricFMSNUWE
Company
Fresenius Medical Care AG
Nuwellis Inc.
Price
-
-
Market cap
$11.41B
$1.8M
1M return
-8.08%
-
1Y return
-12.77%
-
Industry
Misc Health and Biotechnology Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
NYSE
NASDAQ
IPO
News (4w)
6
9
Recent ratings
25
1
FMS

Fresenius Medical Care AG

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

NUWE

Nuwellis Inc.

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Brunei, Germany, Greece, Hong Kong, India, Israel, Italy, Palestine, Singapore, Spain, Switzerland, Thailand, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Latest FMS

Latest NUWE